About 300 reports

  • Insulin pen
  • Pen brands and models differ from one another in many ways.

About Insulin The cost of syringes and insulin pens is low, which enables users to opt for them as first choice devices. High cost of insulin pumps and insulin jet injectors poses a challenge to the growth of the market. Insulin pumps and jet injectors also require special care and maintenance, which is an additional cost burden to...

  • Insulin
  • Eli Lilly & Co.
  • Medtronic, Inc.
  • Novo Nordisk Group
  • Sanofi S.A.
  • CANADA - INSULIN PUMP & PUMP SUPPLIES BY PROVINCE & COVERAGE
  • CANADA - PUBLIC REIMBURSEMENT DETAILS OF INSULIN PUMP & PUMP SUPPLIES BY PROVINCE

Globally, insulin pump market is anticipated to cross US$ 8 Billion by 2024. The growth of diabetes management policy and expansion of diabetes knowledge over the world, the market for insulin pump will develop positive outlook in future year. With the assistance of insulin pump patients deal with their diabetes with a high level...

  • Insulin
  • Western Europe
  • Forecast
  • Insulet Corporation
  • Medtronic, Inc.
  • ONE YEAR (INSULIN PUMP)
  • Market segmentation by product type

About the Insulin Pumps Market Diabetes is a common metabolic disease in which an individual's blood sugar level is high for a prolonged period. This is caused either because the pancreas stops secreting insulin or the body does not respond appropriately to insulin. The two types of diabetes include type 1 and type 2. In type 1 diabetes,...

  • Insulin
  • United States
  • Insulet Corporation
  • Medtronic, Inc.
  • Roche Group
  • Insulin Pumps Outlook
  • Clinical Indications for Insulin Pump Use

Executive Summary A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Insulin Pumps Market By Region (North America, Europe, APAC, MEA and ROW) and By Country (U.S., Canada, Germany,...

  • Insulin
  • Insulin Delivery
  • World
  • Market Size
  • Animas Corporation
  • Insulin Analogue
  • Animal Insulin

China’s demand for Insulin has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption...

  • Insulin
  • China
  • Demand
  • Market Size
  • Eli Lilly & Co.
  • 8.2.1.4 FDA approvals to increase the commercial availability of insulin
  • TANDEM DIABETES CARE, INC.

The insulin delivery devices market is projected to reach USD 17.85 billion by 2021 from USD 11.54 billion in 2016, growing at a CAGR of 9.1% in the next five years (2016 to 2021). Favorable reimbursement scenario and strong government support in selected countries, technological advancements in insulin delivery devices, growing diabetic...

  • Insulin
  • United States
  • Animas Corporation
  • Becton Property Group
  • Eli Lilly & Co.
  • Insulin Analogue
  • Animal Insulin

This study focuses on China’s Insulin industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers...

  • Insulin
  • China
  • Demand
  • Market Size
  • Supply
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT
  • 8.4 BECTON DICKINSON AND CO

BRIC Insulin Delivery Market Outlook to 2022 Summary GlobalData’s new report, "BRIC Insulin Delivery Market Outlook to 2022", provides key market data on the BRIC Insulin Delivery market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Insulin Pens,...

  • Insulin
  • Market Size
  • Eli Lilly & Co.
  • F. Hoffmann-La Roche Ltd.
  • Medtronic, Inc.
  • Insulin Delivery Market Pipeline Products
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

Asia-Pacific Insulin Delivery Market Outlook to 2022 Summary GlobalData’s new report, "Asia-Pacific Insulin Delivery Market Outlook to 2022", provides key market data on the Asia-Pacific Insulin Delivery market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market...

  • Insulin
  • East Asia
  • Market Size
  • B. Braun Melsungen AG
  • Eli Lilly & Co.
  • 8.2.1.4 FDA approvals to increase the commercial availability of insulin
  • TANDEM DIABETES CARE, INC.

The insulin delivery devices market is projected to reach USD 17.85 billion by 2021 from USD 11.54 billion in 2016, growing at a CAGR of 9.1% in the next five years (2016 to 2021). Favorable reimbursement scenario and strong government support in selected countries, technological advancements in insulin delivery devices, growing diabetic...

  • Insulin
  • United States
  • Animas Corporation
  • Becton Property Group
  • Eli Lilly & Co.
  • Insulin: An overview
  • Insulin delivery technologies

About Insulin Beta cells of the pancreas produce insulin, a hormone that regulates blood glucose levels, by stimulating cells to absorb glucose from the blood. In the cells, glucose is converted into energy, which is used by tissues and muscles to perform their physiological functions. This process is restricted in people with diabetes,...

  • Insulin
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Oramed Pharmaceuticals Inc.
  • Sanofi S.A.
  • Profiles of Insulin Producers and Major Insulin
  • Profiles of Insulin Producers and Major Insulin

This study focuses on China’s Insulin industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the...

  • Insulin
  • China
  • Eli Lilly & Co.
  • Hangzhou Sanofi Aventis Minsheng Pharmaceutical Co., Ltd
  • Zhejiang Expressway Co., Ltd.
  • Market in focus: Global non-insulin diabetes therapeutics market ($ mn)
  • MARKET SEGMENTATION ANALYSIS

About Non-insulin Diabetes Therapeutics Non-insulin diabetes therapeutics are mostly administered orally and prescribed when diet and exercise are insufficient to control elevated blood glucose levels. Technavio’s analysts forecast the global non-insulin diabetes therapeutics market to grow at a CAGR of 11.37%...

  • Insulin
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Sanofi S.A.

North America led the insulin biosimilars market due to rising demand for insulin in the region.

  • Insulin
  • APAC
  • Europe
  • World
  • Forecast
  • Insulin Types
  • Benefits and Drawbacks of Insulin Pens

Global Market Watch: The Invasive Devices market is expected to reach US$10.4 billion by 2016 primarily supported by the segments Syringes, Pens, Pumps and Other. Globally, Syringes and Pumps together account for approximately more than 50% of the market and is expected that Insulin Delivery Devices industry to be going forward....

  • Diabetes
  • Insulin
  • Nipro Corporation
  • Novo Nordisk Group
  • Nuova Aptaca SRL

Insulin Resistance - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 ##.

  • Insulin
  • United States
  • World
  • Demand
  • Product Initiative

Methodology List of Tables Table ##.

  • Insulin
  • Therapy
  • World
  • Demand

Methodology List of Tables Table ##.

  • Insulin
  • Therapy
  • World
  • Demand

- How much do the imports of insulin and its salts vary from one country to another?

  • Insulin
  • Therapy
  • World
  • Trade

Insulin Degludec Sales, Price Analysis, & Sales Forecast - 2017 ##.

  • Insulin
  • Therapy
  • World
  • Demand

Insulin Lispro Sales, Price Analysis, & Sales Forecast - 2017 ##.

  • Insulin
  • Therapy
  • World
  • Demand

Insulin Aspart Sales, Price Analysis, & Sales Forecast - 2017 ##.

  • Insulin
  • Therapy
  • World
  • Demand

Insulin Isophane Human Sales, Price Analysis, & Sales Forecast - 2017 ##.

  • Insulin
  • Therapy
  • World
  • Demand

Insulin Regular Human Sales, Price Analysis, & Sales Forecast - 2017 ##.

  • Insulin
  • Therapy
  • World
  • Demand
  • Market segmentation by type of insulin
  • Long-acting insulin

About diabetes Insulin is a hormone produced by beta cells of the pancreas that plays a key role in the regulation of blood glucose levels. It controls the body systems and regulates the uptake of amino acids by body cells. It helps cells absorb glucose from the blood. In diabetics, cells stop responding to the insulin produced. As a result,...

  • Insulin
  • World
  • Lilly Endowment Inc.
  • Novo Nordisk Group
  • Sanofi S.A.

Global Biosimilar Insulin Market Opportunity & Clinical Insight Outlook 2022 ##.

  • Biosimilar
  • Insulin
  • Pathology
  • World
  • Market Size

- How much do the imports of medicaments containing insulin excluding those in dosage form or retail packings vary from one country to another?

  • Insulin
  • Retail
  • Therapy
  • World
  • Trade
  • 3.2.4 Toujeo (insulin glargine) - Sanofi
  • 3.2.2 Levemir (insulin detemir) - Novo Nordisk

Global Diabetes Drugs Market to 2023 - A Diversifying Treatment Landscape as GLP-1 Receptor Agonists and SGLT-2 Inhibitors Gain Ground Following Landmark Cardiac Outcomes Summary Diabetes mellitus (DM) is a generalized term used to define multiple diseases with different etiologies that are characterized by chronic...

  • Insulin
  • World
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • Eli Lilly & Co.
  • Diabetes Care Devices Market Trends and Strategies
  • Data

The diabetes care devices industry manufactures blood glucose monitoring devices and insulin delivery devices. Diabetes care devices are designed to diagnose, monitor or manage type I and type II diabetes mellitus. Diabetes is a chronic disease that occurs either when the pancreas does not produce enough insulin or when the body cannot...

  • Diabetes
  • Insulin
  • World
  • Market Size
  • Medtronic, Inc.
  • Insulin Market in Europe
  • Insulin Market in Europe

About insulin Insulin is a hormone produced by the beta cells of the pancreas; insulin has a key role in regulating the blood glucose levels. It regulates the metabolism of glucose and other nutrients in the body. Insulin permits the body to utilize sugar (glucose) from carbohydrates in the food for energy or to store glucose for future...

  • Insulin
  • Europe
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Sanofi S.A.